Abstract: An abuse deterrent transdermal patch comprising a multilaminate. The multilaminate can comprise a first layer comprising an opioid analgesic compound, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable pressure sensitive adhesive. The multilaminate can further comprise a second layer comprising an opioid antagonist, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable adhesive. In addition, the multilaminate can further comprise a barrier layer disposed between the first and second layers.
Type:
Grant
Filed:
July 17, 2015
Date of Patent:
March 26, 2019
Assignee:
BUZZZ PHARMACEUTICALS LTD.
Inventors:
Audra Lynn Stinchcomb, Dana Carmel Hammell, Stan Lee Banks, Josh Eldridge, Miroslaw Jerzy Golinski